NIH-Funded Research May Help Cancer Patients Suffering From Xerostomia.

Globe Newswire (10/20) carries a release announcing that physicians and researchers at Allegheny Health Network have developed “a promising gene therapy technique” that may help cancer patients suffering from xerostomia, “a common and debilitating side effect of radiation therapy,” according to a pre-clinical study presented Tuesday at the American Society for Radiation Oncology (ASTRO) annual conference. A $1.7 million National Institutes of Health grant supported the project, which “involved the use of an innovative ultrasound procedure, instead of a virus, to facilitate the transfer of therapeutic DNA into cells.”

Globe Newswire (10/20) carries a release announcing that physicians and researchers at Allegheny Health Network have developed “a promising gene therapy technique” that may help cancer patients suffering from xerostomia, “a common and debilitating side effect of radiation therapy,” according to a pre-clinical study presented Tuesday at the American Society for Radiation Oncology (ASTRO) annual conference. A $1.7 million National Institutes of Health grant supported the project, which “involved the use of an innovative ultrasound procedure, instead of a virus, to facilitate the transfer of therapeutic DNA into cells.”